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ABSTRACT  
A series of 4-quinolylhydrazone derivatives was synthesized by reaction of 4-quinolylhydrazine and various substituted carboxaldehyde out of 
that most of the derivatives show significant antitubercular properties. The microwave assisted organic synthesis was applied to synthesize a 
series of 4-quinolylhydrazone derivatives. The characterizations of newly synthesized derivatives were done by modern analytical techniques 
like digital melting point apparatus, IR, NMR and mass spectroscopy.  
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Introduction: 
Tuberculosis (TB) is one of the most predominant infections 
in human beings and it has considerable contribution 
towards illness and death all around the world. Tuberculosis 
is caused by mycobacterium tuberculosis [1]. From previous 
research it is well known that quinolone is an important 
heterocyclic nucleus found in many natural as well as 
synthetic products having wide variety of pharmacological 
activities such as anti-TB [2], tyrokinase PDGF-RKT 
inhibiting agent [3], anticancer [4], antibacterial [5] and anti-
inflammatory [6]. The physicochemical study data of 
quinolone derivatives shows the potential antitubercular 
activity [7].  The literature study of some 4-
quinolylhydrazone derivatives unveiled significant activity 
(MIC=12.5-3.12 µg/ml) when compared to first line drugs 
such as ethambutol (MIC=3.12 µg/ml) [8].  With reference to 
this, in the search of new antituberculosis agents we 
proposed the synthesis of some quinolylhydrazones 
containing 4-hydrazinylquinoline moiety which was 
designed by using molecular modeling methods [9].  From 
literature survey it is observed that quinolylhydrazone 
moiety are pharmacologically very active, shows the 
activities like anti-inflammatory, antimicrobial and 
antitubercular [2]. The latest development in the field of 
organic chemistry is the microwave assisted organic 
synthesis (MAOS) [10], [11] which provides short reaction 
time and economic use of reagents through green approach 
[12]. 
Experimental: 
The synthetic route for the preparation of 4-
quinolylhydrazone derivatives QH1 to QH8 is summarized in 
scheme 1 as below. 
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Scheme 1: 4-quinolylhydrazine, corresponding carboxaldehydes, Ethanol, Microwave (MW) 10-15 min. 
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A Mixture of 4-quinolylhydrazine (1 equivalent), and 
carboxaldehyde (1 equivalent) in absolute ethanol was 
irradiated with temperature assisted microwave oven at 
180W for 10-15 min with intermittence. All the Chemicals 
used are of AR grade from Merck, India. 
The completion of reaction is monitored by TLC. After 
conformation of completion of reaction by TLC the reaction 
mixture is cooled and diluted with water, so that respective 
hydrazones precipitated out from the reaction mixture. The 
product obtained was purified with column chromatography 
by using ethyl acetate and n-hexane to yield expected 
hydrazine derivatives. The purified derivatives were 
recrystallized using suitable organic solvent.  
The molecules understudy are subjected to in-silico studies 
by using Datawarrior software for calculation of properties 
cLogP, cLogS, Total surface area, drug likeness and drug 
score to evaluate the therapeutic properties are summarized 
in table 1 as below. 
 
Table1 
Hydrazones Molecule Formula 
Total Molecular 
weight 
cLogS H-acceptors 
H- 
Donors 
Total 
Surface 
Area 
Drug likeness 
QH1 C16H13N3 247.3 -4.385 3 1 179.6 -2.0672 
QH2 C16H12ClN3 281.745 -5.121 3 1 195.0 -0.2838 
QH3 C16H12N4O2 292.297 -4.845 6 1 203.3 -9.0516 
QH4 C16H12N4O2 292.297 -4.845 6 1 203.3 -7.0604 
QH5 C16H12N4O2 292.297 -4.845 6 1 203.3 -11.868 
QH6 C17H15N3O 277.326 -4.403 4 1 201.89 -1.2243 
QH7 C16H13N3O 263.299 -4.089 4 2 185.98 -1.3401 
QH8 C17H13N3O2 291.309 -4.398 5 5 203.73 -6.1263 
Furthermore the characterizations of hydrazine derivatives were established on the basis of spectral data analysis. 
The synthesized 4-quinolylhydrazone derivatives with their percentage yield, melting point, clogP, drug score and biological 
activities are summarized in table 2 as below. 
Table: 2 
Sr. No. Hydrazones Substitutions % Yield MP (oC) clogP Drug Score 
Biological 
Activity  
1 QH1 R1=R2=R3=H 71 223-224 3.8788 0.39297 0.799 
2 QH2 R3=Cl, R1=R2=H 78 226-227 4.4848 0.41254 0.786 
3 QH3 R1=NO2, R2=R3=H 81 250-252 2.9572 0.34878 0.780 
4 QH4 R2= NO2, R1=R3=H 83 275-278 2.9572 0.34904 0.790 
5 QH5 R3= NO2, R1=R2=H 89 216-218 2.9572 0.34874 0.786 
6 QH6 R3=OCH3, R1=R2=H 76 146-148 3.8088 0.43145 0.786 
7 QH7 R3=OH, R1=R2=H 84 220-221 3.5331 0.45577 0.812 
8 QH8 
R3=COOH, 
R1=R2=H 
80 221-223 3.3639 0.36450 
0.816 
 
Spectral characterization of 4-quinolylhydrazone 
derivatives: 
(Z)-2-benzylidene-1-(quinoline-4yl) hydrazine  
(QH1-C16H13N3):  
1H NMR (DMSO, δ ppm, TMS) 8.18(s,1H), 7.41-8.04(d,4H), 
2.5(s1H), 7.39(t,1H), 7.44(d,1H), 7.51(t,1H), 7.59(d,1H). 13C 
NMR -141, 150.3, 128, 128.9, 130.2, 125.8, 121.0. IR cm-1- 
3070(CH str), 1640(C=N str), 3320(NH str) MS m/z- 
247(100%), 248(18.4%). 
(Z)-2-(4-chlorobenzylidene)-1-(quinoline-4yl)hydrazine  
(QH2-C16H12ClN3): 1H NMR (DMSO, δ ppm, TMS) 
8.17(d,1H), 8.04(d,1H), 8.50(d,1H), 7.30-7.60(m,4H), 
3.95(s,1H). 13C NMR -143.1, 150, 132.1, 136.2, 129, 146.9, 
121, 126.2 IR cm-1 -3070(CH str), 1640(C=N str), 3320(NH 
str), 782(C-Cl) MS m/z-281(100%), 283(32.2%). 
(Z)-2-(2-nitrobenzylidene)-1-(quinoline-4yl)hydrazine 
(QH3-C16H12N4O2):  
1H NMR (DMSO, δ ppm, TMS) 8.25(s,1H), 3.99(s,1H), 7.5-
8.5(d,2H), 7.40-7.60, 8.60(s,1H). 13C NMR -148.1, 144.2, 
149.9, 151.1, 147.5, 149.3, 121.3, 126.1 IR cm-1 -3070(CH 
str), 1640(C=N str), 3320(NH str), 1380(Ar-NO2) MS m/z-
292(100%), 293(17.5%). 
(Z)-2-(3-nitrobenzylidene)-1-(quinoline-4yl)hydrazine  
(QH4-C16H12N4O2):  
1H NMR (DMSO, δ ppm, TMS) 8.20(s,1H), 3.99(s,1H), 1.49-
8.05(d,2H), (8.5(s,1h) 13C NMR -148.6, 143, 149.2, 129.3, 
121, 150.3, 121.6 IR cm-1 -3070(CH str), 1640(C=N str), 
3320(NH str), 1421(Ar-NO2 str) MS m/z-292(100%), 
293(17.5%). 
(Z)-2-(4-nitrobenzylidene)-1-(quinoline-4yl)hydrazine  
(QH5-C16H12N4O2):  
1H NMR (DMSO, δ ppm, TMS) 8.0(s,1H), 8.01(t,2H), 
7.99(t,2H), 8.54(d,1H), 7.49-8.05(d,2H)), 6.41(d,1H) 13C 
NMR -150, 142.9, 121.3, 125.8, 128.8, 130, 130.2, 147.5 IR 
cm-1 -3070(CH str), 1640(C=N str), 3320(NH str), 1489(Ar-
NO2 str) MS m/z-292(100%), 293(17.5%). 
(Z)-2-(4-methoxybenzylidene)-1-(quinoline-
4yl)hydrazine  
(QH6-C17H15N3O): 1H NMR (DMSO, δ ppm, TMS) 8(s,1H), 
3.71(s,3H), 6.71(t,2H), 7.54(t,2H), 3.99(s,1H), 7.67(d,1H), 
7.40(t,1h), 7.60(t,1H), 8.11(d,1H) 13C NMR -60.1, 162.9, 114, 
126.2, 130.4, 115.2, 129.3, 125.4, 121.5, 143.2, 147.6 IR cm-1 
-3070(CH str), 1640(C=N str), 3320(NH str), 1266(Ar-OCH3) 
MS m/z-277(100%), 278(19.5%). 
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(Z)-2-(4-hydroxybenzylidene)-1-(quinoline-
4yl)hydrazine  
(QH7-C16H13N3O):  
1H NMR (DMSO, δ ppm, TMS) 8(s,1H), 10.48(s,1H), 
3.99(s,1H), 6.50(d,1H), 8.69(d,1H), 7.67(d,1H), 7.40(t,1H), 
7.60(t,1H), 8.11(d,1H) 13C NMR -160.7, 115.9, 143, 121, 
125.5, 126.3, 130.3, 148.9 IR cm-1 -3070(CH str), 1640(C=N 
str), 3320(NH str), 1216(Ar-OH) MS m/z-263(100%), 
264(17.5%). 
(Z)-2-(4-formylbenzylidene)-1-(quinoline-
4yl)hydrazine  
(QH8-C17H13N3O2):  
1H NMR (DMSO, δ ppm, TMS) 8(s,1H), 13.26(s,1H), 
3.99(s,1H), 8.10(t,2H), 7.68(t,2H), 7.67(d,1H), 7.40(t,1H), 
7.60(t,1H), 8.11(d,1H) 13C NMR -170.2, 131.8, 130.4, 129.2, 
143, 150.1, 112.4, 129.3, 125.6, 130.4 IR cm-1 -3070(CH str), 
1640(C=N str), 3320(NH str), 1714(Ar-COOH) MS m/z-
291(100%), 292(19.6%). 
Results and Discussion: 
The series of 4-quinolylhydrazone derivatives from QH1 to 
QH8 had been synthesized using microwave assisted 
synthesis. Most of them show a good MIC value when 
compared with the first line drug Ethambutol with a very 
significant antitubercular activity. The TLC plate used is 
coated with alumina, column chromatography on silica gel 
(60-120mesh) was applied when required. 1H NMR spectra 
were recorded on VARIAN NMR spectrophotometer 
operating at 300MHz, TMS is used as internal standard. IR 
spectrum recorded on Shimadzu IR Affinity-1S and mass 
spectra were recorded using water Micromass Q-Tof Mic. 
Conclusion: 
The series of 4-quinolylhydrazone based novel 
antitubercular agents were synthesized and studied by 
advanced and sophisticated instruments. As well as, these 
compounds are also subjected to in-silico studies for their 
therapeutic studies. These compounds shows drug score in 
the range of 0.34 to 0.45 and biological activity of about 0.80 
against mycobacterium tuberculosis. 
In this study it is observed that the hydrazone moiety having 
para substitution with withdrawing groups in benzylidene 
ring shows significant antitubercular activity studied by SAR 
study. In future this can be extended to synthesize more new 
derivatives and to study their practical application as 
potential antitubercular drugs. 
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